Clinical trial
Airway Hyper-responsiveness Study In Asthma Using Salmeterol/Fluticasone…
NCT00291382 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00291382 |
|---|---|
| Title | Airway Hyper-responsiveness Study In Asthma Using Salmeterol/Fluticasone Propionate Combination Product |
| Official title | A Multicentre, Stratified, Randomised, Double Blind, Parallel Group Trial to Evaluate Whether a Treatment Strategy Based on Aiming for Total Control Results in Better AHR Than a Treatment Strategy Based on Maintaining Well Control |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Salmeterol/fluticasone propionate combination |
| Enrollment | 150 |
| Start date | Nov 1, 2005 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Feb 14, 2006 |
| Last update posted | May 30, 2017 |
| Countries | Belgium, Estonia, Finland, France, Germany, Italy, Latvia, Netherlands, Spain, Sweden |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: